Accrued liabilities as of June 30, 2024 and December 31, 2023 consisted of the following:
June 30,
December 31,
2024
2023
Accrued personnel related costs
$
1,024
1,989
Accrued research and development expenses
4,054
6,527
Other accrued expenses
118
313
Total
5,196
8,829
No definition available.
Tabular disclosure of the components of accrued liabilities.